There’s a common claim circulating in research and peptide communities that RETA should be discarded 28–30 days after reconstitution. But that number is often treated as a default safety guideline, not a strict biochemical expiration point. When you look at peptide stability data more closely, the picture becomes more nuanced. The 30-Day Rule: Where It Comes From The “30-day discard” recommendation is typically based on: - sterility risk over time - general pharmacy compounding guidelines - conservative safety assumptions - bacterial contamination potential In other words: it’s primarily a microbiological safety guideline, not a direct measure of molecular degradation What Stability Data Suggests In peptide stability research, certain compounds stored under controlled conditions have shown extended structural integrity. When stored properly (refrigerated, protected from light, and maintained in sterile conditions), some peptides have demonstrated: - minimal degradation over extended periods - retained structural integrity beyond typical discard windows - high remaining purity over time under ideal conditions In some observed stability analyses, peptides remained near baseline purity levels (around 99%) over extended refrigerated storage periods. Important note: this refers to controlled laboratory conditions, not uncontrolled or contaminated environments Why Storage Conditions Matter More Than Time Alone Peptide degradation is influenced less by time alone and more by environmental exposure. Key factors include: 1. Temperature Stability - consistent refrigeration slows degradation - temperature fluctuations accelerate instability 2. Light Exposure - UV and direct light can accelerate breakdown - opaque or dark storage conditions are preferred in research handling 3. Sterility (Most Important Factor) The most significant risk is not molecular decay — it is contamination. bacterial contamination is the fastest way to render a solution unusable

One of the most common points of confusion in peptide preparation is how much bacteriostatic water (“bac water”) to add to a vial. While it looks complicated at first, the system becomes very simple once you understand the relationship between mass (mg) and volume (mL). This is strictly an educational breakdown of reconstitution principles used in research discussions. The Core Concept: It’s All About Concentration Reconstitution is not about a universal fixed amount of water — it’s about creating a usable concentration. Two key variables define everything: - Peptide amount (mg) = total compound in the vial - Bacteriostatic water (mL) = dilution volume Together, they create: mg per mL (concentration) This is what determines how syringe units translate into actual compound amounts. Example 1: 10 mg Vial A simple, commonly used educational ratio: - 10 mg peptide - 1 mL bac water This produces: 10 mg / 1 mL = 10 mg per mL concentration On a standard insulin syringe: - 100 units = 1 mL - 10 units = 0.1 mL So in this setup: - 10 units = 1 mg - 20 units = 2 mg - 40 units = 4 mg Example 2: 30 mg Vial Scaling the same logic: - 30 mg peptide - 3 mL bac water This also produces: 10 mg per mL concentration Meaning the syringe conversions remain identical: - 10 units = 1 mg - 20 units = 2 mg - 40 units = 4 mg The key benefit here is consistency — once the ratio is understood, the math stays linear. Why This Confuses So Many People Most confusion comes from mixing up three separate ideas: - Volume (mL or syringe units) - Total compound amount (mg) - Concentration (mg/mL) A syringe only measures: liquid volume It does not indicate how much active compound is present unless the concentration is known. Why Standard Ratios Are Used Using proportional reconstitution methods (like 1 mL per 10 mg or 3 mL per 30 mg) helps because: - calculations remain consistent - syringe measurements become predictable - interpretation is easier across different vial sizes - errors from mental math are reduced in theoretical discussions

Most people hear “fat loss” and think calories, cardio, or appetite suppression. MOTS-c doesn’t really fit that category. It’s better understood as a mitochondrial signal — one that influences how your cells communicate energy demand, stress, and adaptation. This isn’t about forcing change. It’s about shifting how your body responds to change. WEEK 1: SOMETHING FEELS DIFFERENT You may notice: - slightly more stable energy - fewer post-meal crashes - reduced cravings What’s happening: MOTS-c is associated with activation of AMPK pathways, which are central to cellular energy sensing. Your body starts becoming more efficient at recognizing energy availability and glucose handling begins to improve. WEEK 2: YOUR BODY STARTS SWITCHING FUEL You may notice: - more consistent energy through the day - less reliance on sugar - feeling lighter after eating What’s happening: Insulin sensitivity begins improving and glucose spikes may reduce. At this stage, the body starts shifting toward more flexible fuel utilization — including increased fat oxidation signaling. WEEK 3: FAT LOSS STARTS FEELING “AUTOMATIC” You may notice: - reduced appetite - less bloating - a “leaner” feeling without trying What’s happening: Mitochondrial efficiency improves and fat oxidation pathways become more active. Low-grade inflammation signaling may also begin to reduce, improving overall metabolic output. WEEK 4: YOUR METABOLISM STOPS FIGHTING YOU You may notice: - steady energy without crashes - improved training output or easier movement - clearer mental focus What’s happening: Mitochondrial function becomes more efficient at producing ATP (cellular energy), improving energy output per unit of fuel. Muscle tissue begins using energy more effectively. WEEK 5: BODY RECOMPOSITION SIGNALS You may notice: - gradual leanness without major effort - faster recovery - better physical definition What’s happening: Metabolic flexibility improves — meaning your body becomes better at switching between fuel sources (fat and glucose).